Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/9/13 → 3/31/17 |
Funding
- Parexel (Prot #R668-AD-1307 // Prot #R668-AD-1307)
- Regeneron Pharmaceuticals, Inc. (Prot #R668-AD-1307 // Prot #R668-AD-1307)
Prot #R668-AD-1307: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Investigating the Efficacy, Safety, Serum Concentration, and Biomarker Profile of Dupilumab Administered to Adult Patients with Moderate-to-Severe Atopic Dermatitis
- Paller, Amy (PD/PI)
- Silverberg, Jonathan I (PD/PI)
Project: Research project